Vertex Pharmaceuticals (United States)

1.5k papers and 87.2k indexed citations i.

About

In recent decades, authors affiliated with Vertex Pharmaceuticals (United States) have published 1.5k papers, which have received a total of 87.2k indexed citations. Scholars at this organization have produced 525 papers in Molecular Biology, 187 papers in Pulmonary and Respiratory Medicine and 159 papers in Oncology on the topics of Therapeutic Advances in Cystic Fibrosis Research (157 papers), Hepatitis C virus research (135 papers) and Computational Drug Discovery Methods (106 papers). Their work is cited by papers focused on Molecular Biology (40.6k citations), Epidemiology (13.0k citations) and Pulmonary and Respiratory Medicine (11.8k citations). Authors at Vertex Pharmaceuticals (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Nature, Science and Cell. Some of Vertex Pharmaceuticals (United States)'s most productive authors include Mark A. Murcko, W. Patrick Walters, Keisuke Kuida, Guy W. Bemis, Michael Su, David A. Pearlman, Paul S. Charifson, David J. Livingston, Ursula A. Germann and Ann D. Kwong.

In The Last Decade

Fields of papers published by authors at Vertex Pharmaceuticals (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Vertex Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Vertex Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Vertex Pharmaceuticals (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Vertex Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Vertex Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vertex Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Millennium Engineering and Integration (United States) Breakdown of academic impact, for scholars at Wallops Flight Facility Breakdown of academic impact, for scholars at Centre for Inflammation Research Breakdown of academic impact, for scholars at Pathways Behavioral Services Breakdown of academic impact, for scholars at Chedoke Hospital Breakdown of academic impact, for scholars at Interfaces, Confinement, Matériaux et Nanostructures Breakdown of academic impact, for scholars at Institute for Behavioral Medicine Breakdown of academic impact, for scholars at Psychiatry Research Trust